Literature DB >> 21814038

Transcriptional and epigenetic regulation of the p53 tumor suppressor gene.

Ricardo Saldaña-Meyer1, Félix Recillas-Targa.   

Abstract

The p53 tumor suppressor is one of the most studied molecules in cancer research. Despite the fact that there is a detailed understanding involving multiple aspects of the p53-associated biology, many aspects of its transcriptional regulation are still not well clarified. Limited information is available on how the p53 gene is transcriptional and epigenetically regulated. The p53 gene expression is tightly controlled through a variety of transcription factors, miRNAs, its anti-sense RNA Wrap53, the insulator protein CTCF and very likely by other genetic and epigenetic mechanisms. It's the intent of this article to review in depth important aspects concerning the transcriptional regulation of the p53 gene and perhaps serve as a stepping-stone to begin a conceptual change on how future p53 research can be approached.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21814038     DOI: 10.4161/epi.6.9.16683

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  42 in total

1.  Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.

Authors:  Annemarie Koch; Jiri Hatina; Harald Rieder; Hans-Helge Seifert; Wolfgang Huckenbeck; Frank Jankowiak; Andrea R Florl; Robert Stoehr; Wolfgang A Schulz
Journal:  Cell Oncol (Dordr)       Date:  2012-06-06       Impact factor: 6.730

2.  A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.

Authors:  Yanding Zhao; Frederick S Varn; Guoshuai Cai; Feifei Xiao; Christopher I Amos; Chao Cheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-15       Impact factor: 4.254

3.  Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.

Authors:  Jeffrey S Buzby; Shirley A Williams; Lana Schaffer; Steven R Head; Diane J Nugent
Journal:  Cancer Genet       Date:  2017-01-09

4.  Regulation of the p53 expression profile by hnRNP K under stress conditions.

Authors:  Agata Swiatkowska; Mariola Dutkiewicz; Piotr Machtel; Damian M Janecki; Martyna Kabacinska; Paulina Żydowicz-Machtel; Jerzy Ciesiołka
Journal:  RNA Biol       Date:  2020-05-29       Impact factor: 4.652

5.  A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.

Authors:  Claudia Fabiola Méndez-Catalá; Svetlana Gretton; Alexander Vostrov; Elena Pugacheva; Dawn Farrar; Yoko Ito; France Docquier; Georgia-Xanthi Kita; Adele Murrell; Victor Lobanenkov; Elena Klenova
Journal:  Neoplasia       Date:  2013-08       Impact factor: 5.715

Review 6.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Authors:  Flore Kruiswijk; Christiaan F Labuschagne; Karen H Vousden
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07       Impact factor: 94.444

Review 7.  A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.

Authors:  Craig L Parfett; Daniel Desaulniers
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

8.  The tumor suppressor role of PAQR3 in osteosarcoma.

Authors:  Zhiqiang Ma; Yanlong Wang; Taikui Piao; Zhaopeng Li; Hongyu Zhang; Zhixin Liu; Jianyu Liu
Journal:  Tumour Biol       Date:  2014-12-17

9.  Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response.

Authors:  Fernando J López-Díaz; Philippe Gascard; Sri Kripa Balakrishnan; Jianxin Zhao; Sonia V Del Rincon; Charles Spruck; Thea D Tlsty; Beverly M Emerson
Journal:  Mol Cell       Date:  2013-05-23       Impact factor: 17.970

10.  Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.

Authors:  Shabirul Haque; Xiao Jie Yan; Lisa Rosen; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.